ACETAZOLAMIDE

Substance profile for UNII O3FX965V0I, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ACETAZOLAMIDE
Structure render from PubChem CID 1986

Substance Identity#

UNII
O3FX965V0I
Preferred term
ACETAZOLAMIDE
Registry number
59-66-5
EC number
200-440-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C4H6N4O3S2
Chemical structure for ACETAZOLAMIDE
Structure render from PubChem CID 1986

Chemical And Database Identifiers#

InChIKey
BZKPWHYZMXOIDC-UHFFFAOYSA-N
SMILES
CC(=O)NC1=NN=C(S1)S(N)(=O)=O
RxCUI
167
PubChem
1986
NCIt
C28809
INN ID
481

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0I59050278-167e-4641-a253-4e57653f8b6b2
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0I59050278-167e-4641-a253-4e57653f8b6b2
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IAcetaZOLAMIDE TABLETS USP1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IAcetaZOLAMIDE TABLETS USP1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.]22
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.]19
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [HERITAGE PHARMACEUTICALS INC.]12
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [HERITAGE PHARMACEUTICALS INC.]12
acetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS]4
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.]4
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.]4
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [LANNETT COMPANY, INC.]4
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [LANNETT COMPANY, INC.]4
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]4
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]4
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.]3
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.]3
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]3
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]3
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [BARR LABORATORIES INC..]3
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [BARR LABORATORIES INC..]3
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HERITAGE PHARMACEUTICALS INC.]3
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IDIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.]3
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IDIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.]3
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [AMERICAN HEALTH PACKAGING]2
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [AMERICAN HEALTH PACKAGING]2
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]2
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]2
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]2
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]2
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IDIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]2
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IDIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]2
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [KAISER FOUNDATION HOSPITALS]1
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [KAISER FOUNDATION HOSPITALS]1
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [A-S MEDICATION SOLUTIONS LLC]1
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [A-S MEDICATION SOLUTIONS LLC]1
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [A-S MEDICATION SOLUTIONS LLC]1
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [A-S MEDICATION SOLUTIONS LLC]1
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [CARDINAL HEALTH]1
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [CARDINAL HEALTH]1
AcetazolamideACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [CARDINAL HEALTH]1
AcetazolamideACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [CARDINAL HEALTH]1
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [MARLEX PHARMACEUTICALS INC]1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [MARLEX PHARMACEUTICALS INC]1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]1
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]1
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [REMEDYREPACK INC. ]1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [REMEDYREPACK INC. ]1
ACETAZOLAMIDEACTIVE INGREDIENTO3FX965V0IACETAZOLAMIDE TABLET [REMEDYREPACK INC. ]1
ACETAZOLAMIDEACTIVE MOIETYO3FX965V0IACETAZOLAMIDE TABLET [REMEDYREPACK INC. ]1